ArticleClinical and translational gastroenterology2026
Reverse Endoscopic Full-Thickness Resection for Gastric Submucosal Tumors With a Predominant Extraluminal Growth Pattern.
Article in Clinical and translational gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionLarge gastrointestinal stromal tumors (GISTs) exhibiting a predominantly extraluminal growth pattern are characterized by a rich vascular supply and close proximity to adjacent organs, which pose significant challenges for endoscopic full-thickness resection. The aim of this study was to evaluate the feasibility and therapeutic outcomes of reverse endoscopic full-thickness resection (R-EFTR) for gastric GISTs with a predominantly extraluminal growth pattern.
methodsWe conducted a retrospective analysis of 43 consecutive patients who underwent R-EFTR for gastric GISTs exhibiting a predominant extraluminal growth pattern between March 2019 and December 2024. Data on clinicopathologic characteristics, surgical parameters, and follow-up outcomes were collected and analyzed.
resultsTumor sizes ranged from 2.0 to 5.0 cm, and en bloc resection by R-EFTR was successfully achieved in 41 tumors (95.3%). Notably, tumors larger than 3 cm significantly prolonged operative times ( P < 0.001). Successful closure of gastric wall defects was accomplished using through-the-scope twin clips in 41.9% of cases, while 58.1% were closed using endoloop clips. Closure with endoloop clips was associated with longer procedure time ( P = 0.037). The postoperative follow-up completion rate was 100%, achieved through clinic visits combined with endoscopic ultrasound and computed tomography. During the follow-up period, no patients experienced recurrence or metastasis. DISCUSSION: The findings of our study suggest that R-EFTR is a viable and effective treatment option for GISTs that exhibit a predominantly extraluminal growth pattern and measure between 2 and 5 cm. Tumor size greater than 3 cm was associated with increased procedural complexity, whereas the association with endoloop-clip closure should be interpreted cautiously.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.